LONG-TERM OUTCOMES OF COGNITIVE BEHAVIORAL THERAPY VERSUS PHARMACOTHERAPY IN ANXIETY DISORDERS

Abstract

This paper aimed at evaluating and comparing the efficacy of cognitive-behavioral therapy (CBT) and pharmacotherapy in anxiety disorders, in terms of symptoms remission, relapse, functional recovery, and treatment sustainability. It was a longitudinal mixed-methods design, which incorporated both quantitative measures of the severity of the symptoms and qualitative patient outcomes, during long durations of time. The efficacy of the treatment in the long run was measured using standardized anxiety scales, relapse indicators and functional assessments. CBT and pharmacotherapy resulted in significant short-term reduction in anxiety symptoms. However, CBT showed significantly better long-term symptom stability, lower rates of relapse as well as long-term beneficial functional improvements compared to pharmacotherapy. CBT patients were also able to cope better, were more confident about their capacity to deal with issues and the necessity of continued clinical support was reduced.